FDA Inspection 1069126 — New York Blood Center, Inc.
The FDA completed an inspection of New York Blood Center, Inc. on September 18, 2018 in Paramus, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 18, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Paramus, NJ (United States)